Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study).

Journal:
Journal of Clinical Oncology
Published:
DOI:
10.1200/jco-25-02021
Affiliations:
4
Authors:
16
Go to article
Institutions Authors Share
Fudan University Shanghai Cancer Center (FUSCC), China
7.333333
 0.46
Shanghai Medical College (SHMC), Fudan University, China
6.666667
 0.42
Hengrui, China
2.000000
 0.13
Interested in Clinical Sciences?